8-K
Current Report
Damora Therapeutics, Inc. Filed Acc 0000950170-23-000283
Results of operations · Regulation FD disclosure
- Item 2.02 Results of operations and financial condition
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading glto-20230106.htm…